Berlin Bio Innovation Day

​Showcasing the next wave of life science innovation 🧬🚀

​Join us for an afternoon and evening celebrating early-stage life science and health innovation in Berlin and beyond. The program brings together keynotes, an expert panel, and pitches from promising startups. End the evening with networking among top founders, investors and ecosystem leaders 🔬💡

​📅 Preliminary Schedule
(subject to change)

• ​14:30 – 15:15 | Arrival & Check-in

• ​15:15 – 15:30 | Opening Remarks

• ​15:30 – 15:50 | Keynote – Johannes Fruehauf (CEO, BioLabs & Mission BioCapital)

• ​15:50 – 16:30 | Panel – Enabling Innovation Ecosystems

• ​16:30 – 16:50 | Coffee Break

• ​16:50 – 17:05 | Keynote – Manuel Grossmann (Founding Partner, Amino Collective)

• ​17:05 – 19:05 | Startup Pitches – 12 teams, 4 min each (with a break in the middle, don't worry!)

• ​19:15 – 22:00 | Networking Dinner & Drinks

​Featured Startups

​𝗔𝗸𝗮𝘀𝗶 𝗣𝗵𝗮𝗿𝗺𝗮 · Best-in-class therapeutics for neuropathic pain using a new modality on a clinically validated target
𝗔𝗿𝘃𝗮𝗹𝘂𝘀 𝗧𝗵𝗲𝗿𝗮𝗽𝗲𝘂𝘁𝗶𝗰𝘀 · Live biotherapeutic product tackling multi-drug-resistant gut pathogens
𝗕𝗹𝘂𝗲𝗽𝗿𝗶𝗻𝘁 𝗕𝗶𝗼𝗺𝗲𝗱 · Biodegradable, off-the-shelf implant that harnesses the body's healing capacity for safer, faster bone regeneration
𝗖𝗮𝗽𝘁𝗮𝗶𝗻 𝗧 𝗖𝗲𝗹𝗹 · Next-gen TCR-T cell therapies for solid tumor patients
𝗖𝗢𝗟𝗜𝗣𝗜 · Potentially the world's fastest bio-CCU process, turning CO2 into value
𝗖𝘂𝗹𝘁𝗶𝗺𝗮𝘁𝗲 𝗙𝗼𝗼𝗱𝘀 · Cultivated flavoring ingredients that deliver the taste of real meat
𝗗𝗲𝗻𝘀𝗲 𝗜𝗺𝗺𝘂𝗻𝗲 · Bioengineered HCMV immunotherapy for transplant patients and newborns
𝗘𝗡𝗗𝗨𝗥𝗜𝗩𝗔𝗖 · One shot - durable immunity with a novel, single-dose vaccine vector
𝗙𝘂𝘀𝗶𝘅 𝗕𝗶𝗼𝘁𝗲𝗰𝗵 · Precision-engineered oncolytic virus platform that kills solid tumors and unlocks immune response
𝗚𝗿𝗲𝗲𝗻 𝗘𝗹𝗲𝗽𝗵𝗮𝗻𝘁 𝗕𝗶𝗼𝘁𝗲𝗰𝗵 · Life Sciences tool provider for Cell and Gene Therapies
𝗜𝗖𝗛𝗢𝗥𝘁𝗲𝗰 · Direct free energy measurement for DNA, RNA, and proteins with pass/fail rules for decisions
𝗜𝗺𝗺𝘂𝗻𝗲𝗔𝗱𝘃𝗶𝗰𝗲 · CD4 ICE-T: first non-invasive tracer for early detection of immune checkpoint inhibitor resistance
𝗠𝗶𝗺𝗼𝘁𝘆𝗽𝗲 𝗧𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝗶𝗲𝘀 · Genetically programs Optically Active Proteins to create light-biomatter sensors for tissue engineering and quantum biology
𝗠𝘆𝗜𝗺𝗺𝘂𝗻𝗲 · AI unlocking the immune system for better therapies, earlier diagnostics and better outcomes
𝗻𝗮𝘄𝘂 𝗱𝗶𝗮𝗴𝗻𝗼𝘀𝘁𝗶𝗰𝘀 · Rapid, breath-based diagnostics for respiratory infections enabling decentralized care
𝗡𝗲𝘂𝘁𝗿𝗼𝗚𝗲𝗻 𝗧𝗵𝗲𝗿𝗮𝗽𝗲𝘂𝘁𝗶𝗰𝘀 · Developing first neutrophil cell transfusion therapy for critical neutropenia
𝗢𝗽𝘁𝗼𝗩𝗔𝗫 · Platform technology to produce live-attenuated parasites
𝗢𝗿𝗯𝗶𝗼𝗻 · Accelerates disease research with ML models that characterize proteins and generate experiment-ready protocols
𝗣𝗔𝗠 𝗧𝗵𝗲𝗿𝗮𝗴𝗻𝗼𝘀𝘁𝗶𝗰𝘀 · First-in-class therapeutic platform targeting peptide hormone activation for neurovascular and neuroinflammatory diseases
𝗣𝗮𝗻𝗼𝘀𝗼𝗺𝗲 · Antibodies targeting small epitopes using proprietary VAST platform for high-specificity cancer therapy
𝗤𝘂𝗮𝗻𝘁𝗶𝗟𝗶𝗴𝗵𝘁 · Portable blood testing platform using patented bioluminescent sensors for rapid Therapeutic Drug Monitoring and clinical trials
𝗧𝗲𝗻𝗲𝘂𝗿𝗮 𝗧𝗵𝗲𝗿𝗮𝗽𝗲𝘂𝘁𝗶𝗰𝘀 · T cell therapies for neurological autoimmune diseases

​About the Event Host

​​​Nucleate is a 501(c)(3) nonprofit organization dedicated to empowering the next generation of biotech leaders. With chapters spanning 41 geographic regions and participation from over 280 academic institutions, Nucleate sparks new intellectual communities and embeds emerging talent within a global biotech community. Through open-access educational programming, Nucleate helps democratize biotech innovation — removing barriers and helping founders concentrate on building transformational technologies. Visit www.nucleate.org for more information, and visit https://nucleate.org/privacy-policy/ to read our privacy policy.